TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1832287

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) 3 pmol kg-1 min-1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) 15 pmol kg-1 min-1
Number of subjects: 8

Group type: COMPARATOR
Intervention: Metoclopramide (10 mg slow i.v.)
Number of subjects: 8
Study: 6187064

Group type: EXPERIMENTAL
Intervention: Isoprinosine administered for 60 days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Prednisone administered for 60 days (Control)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: CSF examination for IgG oligoclonal bands
Number of subjects: 11
Study: 31150084

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Group Psychotherapy (GPT)
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Individual Clinical Management (CM)
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory
Number of subjects: 433
Study: 29069046

Group type: EXPERIMENTAL
Intervention: Craniotomy surgery (Group A, n=21)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Burr hole, urokinase infusion and catheter drainage (Group B, n=22)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Neuroendoscopic surgery (Group C, n=20)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 63
Study: 26607842

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (without PRF)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both PRF and Control
Number of subjects: 56
Study: 23312343

Group type: EXPERIMENTAL
Intervention: Complete thymectomy
Number of subjects: 32

Group type: COMPARATOR
Intervention: No thymectomy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Partial thymectomy
Number of subjects: 32
Study: 21727100

Group type: EXPERIMENTAL
Intervention: Standardization of medication-ordering, reliable medication-dispensing processes, reliable medication-administration processes, improvement of patient safety culture, clinical decision support.
Number of subjects: 13
Study: 19211654

Group type: EXPERIMENTAL
Intervention: Dynamic Exercise Programme (DEP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional joint rehabilitation group
Number of subjects: 50
Study: 15915004

Group type: EXPERIMENTAL
Intervention: 1 mg clonazepam
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 14601351

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy self-help facilitated by practice nurses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ordinary care by GPs
Number of subjects: 0
Study: 10387403

Group type: EXPERIMENTAL
Intervention: Treatment trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prevention trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Narrow inclusion criteria
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective participation in treatment RCTs
Number of subjects: 0
Study: 8699577

Group type: EXPERIMENTAL
Intervention: K-Y diet (rice-lentil-yogurt)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Milk protein-based lactose free formula
Number of subjects: 30

Group type: COMPARATOR
Intervention: Soy protein formula
Number of subjects: 30
Study: 2025847

Group type: EXPERIMENTAL
Intervention: Radical surgery
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Definitive radiation therapy
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Resection plus irradiation
Number of subjects: 215

Group type: COMPARATOR
Intervention: Conventionally fractionated irradiation with less intense chemotherapy
Number of subjects: 215

Group type: COMPARATOR
Intervention: Hyperfractionated irradiation with simultaneous chemotherapy
Number of subjects: 215
Study: 6625781

Group type: EXPERIMENTAL
Intervention: Continuous oxygen treatment (COT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Nocturnal oxygen treatment (NOT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Both COT and NOT
Number of subjects: 150
Study: 31586204

Group type: EXPERIMENTAL
Intervention: Using sunscreen (Condition 1, n = 259)
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: Seeking shade (Condition 2, n = 245)
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: Covering up (Condition 3, n = 289)
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Multibehavior message (Condition 4, Control, n = 251)
Number of subjects: 1044
Study: 29975462

Group type: EXPERIMENTAL
Intervention: Ranirestat (40 mg/day)
Number of subjects: 557

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 557
Study: 28681612

Group type: EXPERIMENTAL
Intervention: M + A group (mothers and adolescents)
Number of subjects: 1455

Group type: EXPERIMENTAL
Intervention: A group (adolescents only)
Number of subjects: 1455

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1455
Study: 25656503

Group type: EXPERIMENTAL
Intervention: Web-based contingency management program (CM)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Phone-delivered cessation counseling program (SCHB)
Number of subjects: 17
Study: 24973990

Group type: EXPERIMENTAL
Intervention: Reduced Forced Expiratory Volume in 1 Second (FEV1)
Number of subjects: 1307

Group type: EXPERIMENTAL
Intervention: Peripheral Artery Disease (PAD)
Number of subjects: 1307

Group type: EXPERIMENTAL
Intervention: Combined reduced FEV1 and PAD
Number of subjects: 1307
Study: 21638103

Group type: EXPERIMENTAL
Intervention: Radiosynoviorthesis
Number of subjects: 0
Study: 19207347

Group type: EXPERIMENTAL
Intervention: 12-Step directive approach to facilitating AA
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Motivational enhancement approach to facilitating AA
Number of subjects: 169

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 169
Study: 17169168

Group type: EXPERIMENTAL
Intervention: Breathing of 100% O2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 0
Study: 15868260

Group type: EXPERIMENTAL
Intervention: Transanal endoscopic microsurgery (TEM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Laparoscopic resection (LR)
Number of subjects: 40
Study: 11874605

Group type: EXPERIMENTAL
Intervention: Invasive positive‐pressure ventilation (IPPV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noninvasive positive‐pressure ventilation (NPPV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: IPPV
Number of subjects: 0
Study: 9523307

Group type: EXPERIMENTAL
Intervention: Oral bidisomide co-administration with breakfast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous bidisomide infusion with high fat breakfast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral bidisomide co-administration with viscous homogenized solid meals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral non-caloric hydroxypropyl methylcellulose meals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral, duodenal, and mid-jejunal administration of disopyramide in dogs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral bidisomide administration in dogs with solid meal co-administration
Number of subjects: 0
Study: 7639300

Group type: EXPERIMENTAL
Intervention: Betaxolol
Number of subjects: 13

Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 13
Study: 2678210

Group type: EXPERIMENTAL
Intervention: Nadolol (beta blocker)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Relaxation therapy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Combined beta blocker and relaxation therapy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Health education
Number of subjects: 47
Study: 577445

Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg daily
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 30479099

Group type: EXPERIMENTAL
Intervention: Less radical hysterectomy (RH) regarding parametrectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trachelectomy (vaginal or abdominal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Minimally invasive surgery
Number of subjects: 0
Study: 29171487

Group type: EXPERIMENTAL
Intervention: neuromultivit and basic therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: basic therapy
Number of subjects: 100
Study: 25653188

Group type: EXPERIMENTAL
Intervention: Home HPV test
Number of subjects: 63

Group type: COMPARATOR
Intervention: Clinic Pap test
Number of subjects: 63
Study: 23397863

Group type: EXPERIMENTAL
Intervention: Normobaric hyperoxia (NBO), 100% oxygen (O2) at 1 atmosphere absolute (atm abs) for 90 minutes
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ambient air
Number of subjects: 18
Study: 22139799

Group type: EXPERIMENTAL
Intervention: Local anesthesia with lidocaine spray (10gr/100ml) in Group A (≤65 years)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Local anesthesia with lidocaine spray (10gr/100ml) in Group B (>65 years)
Number of subjects: 248
Study: 19695646

Group type: EXPERIMENTAL
Intervention: Full spectrum therapy with pelvic floor muscle training
Number of subjects: 63

Group type: COMPARATOR
Intervention: Full spectrum therapy without pelvic floor muscle training (Control)
Number of subjects: 63
Study: 16645428

Group type: EXPERIMENTAL
Intervention: Reliéva (Mahonia aquifolium extract) topical cream, applied twice a day for 12 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo topical cream, applied twice a day for 12 weeks
Number of subjects: 200
Study: 11895160

Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN) supplemented with soybean oil (SO, Lipovenoess 10% PLR; 1.0 g/kgBW per day; n = 20)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) supplemented with a combination of fish oil (FO, Omegaven; 0.2 g/kgBW per day) and soybean oil (SO, Lipovenoes 10% PLR; 0.8 g/kgBW per day; n = 24)
Number of subjects: 44
Study: 9495408

Group type: EXPERIMENTAL
Intervention: i.v. droperidol
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: epidural droperidol
Number of subjects: 97

Group type: COMPARATOR
Intervention: no droperidol injection
Number of subjects: 97
Study: 8535553

Group type: EXPERIMENTAL
Intervention: Indomethacin 25 mg three times daily
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 2118403

Group type: EXPERIMENTAL
Intervention: Provision of raised toilet seat
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: Provision of teapot tipper
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: Provision of tap turner
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: Provision of double handled saucepan
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: Provision of shoe horn
Number of subjects: 744
Study: 300048

Group type: EXPERIMENTAL
Intervention: Sulindac (twice daily dosage for 5 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sulindac (twice daily dosage)
Number of subjects: 0
Study: 27162452

Group type: EXPERIMENTAL
Intervention: Peribulbar block
Number of subjects: 152

Group type: COMPARATOR
Intervention: Posterior sub-Tenon block
Number of subjects: 152
Study: 24570217

Group type: EXPERIMENTAL
Intervention: Tele-health program (MoodCare)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 121
Study: 23973636

Group type: EXPERIMENTAL
Intervention: American ginseng (AG) 3g daily for 12 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 20713813

Group type: EXPERIMENTAL
Intervention: Narrowband UV-B treatment 3 times per week
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 60
Study: 17544842

Group type: EXPERIMENTAL
Intervention: 20m square shuttle run test (SST)
Number of subjects: 74

Group type: COMPARATOR
Intervention: 20m Multistage Shuttle Run Test (MST)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Treadmill test (TT)
Number of subjects: 74
Study: 16791967

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 12093831

Group type: EXPERIMENTAL
Intervention: OC + metformin
Number of subjects: 40

Group type: COMPARATOR
Intervention: OC
Number of subjects: 40
Study: 9560053

Group type: EXPERIMENTAL
Intervention: Full-dose anthracycline-containing regimens similar to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three cycles of CHOP chemotherapy followed by involved field irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anthracyclines with reduced cardiotoxicity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hematopoietic growth factors and/or cardioprotective drugs
Number of subjects: 0
Study: 7643821

Group type: EXPERIMENTAL
Intervention: 20 mg ketoprofen lysine salt suppositories
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 30 mg ketoprofen lysine salt suppositories
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 40 mg ketoprofen lysine salt suppositories
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 60 mg ketoprofen lysine salt suppositories
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: 80 mg ketoprofen lysine salt suppositories
Number of subjects: 107
Study: 2751841

Group type: EXPERIMENTAL
Intervention: Ketotifen 0.35 mg every 12 hours
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 782977

Group type: EXPERIMENTAL
Intervention: Oral killed typhoid vaccine (100.10^9 killed S. typhi)
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: Oral killed typhoid vaccine (300.10^9 killed S. typhi)
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: Oral killed typhoid vaccine (400.10^9 killed S. typhi)
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6000
Study: 31302768

Group type: COMPARATOR
Intervention: Group I: inferior alveolar nerve block (IANB) of 2% lidocaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group II: IANB and buccal infiltration (BI) of 4% articaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group III: IANB + BI and intraseptal injection of articaine
Number of subjects: 90
Study: 29703998

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OXT) administration
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (PLC) administration
Number of subjects: 58
Study: 28370178

Group type: EXPERIMENTAL
Intervention: Curcuma (6 g containing 2% curcumin)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 26438237

Group type: EXPERIMENTAL
Intervention: Short-term fasting (STF) 24 hours before and after chemotherapy
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (non-STF)
Number of subjects: 13
Study: 23504523

Group type: EXPERIMENTAL
Intervention: Increase in physical activity score by 23 units
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decrease in BMI by 1.9 units
Number of subjects: 0
Study: 21722581

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM) for ≥ 48 days
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM) for <48 days
Number of subjects: 100
Study: 19808351

Group type: EXPERIMENTAL
Intervention: Serial B-type natriuretic peptide testing (at 3, 6, 9, and 12 hours then daily)
Number of subjects: 447

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Serial B-type natriuretic peptide testing
Number of subjects: 447
Study: 17584566

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 15386625

Group type: EXPERIMENTAL
Intervention: Diffusion tensor tractography and voxel-based analysis in ALS patients
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (11 age- and sex-matched volunteers)
Number of subjects: 7
Study: 11435883

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (240 ml, 3 times daily for 7 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (tap water, 240 ml, 3 times daily for 7 days)
Number of subjects: 10
Study: 9682700

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 1439

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: Intensive treatment with early worsening
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: Higher hemoglobin A1c level at screening
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: Reduction of hemoglobin A1c during the first 6 months
Number of subjects: 1439

Group type: EXPERIMENTAL
Intervention: Intensive treatment initiation
Number of subjects: 1439
Study: 8026287

Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acids (HMUFA) diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-complex carbohydrates (high-CHO) diet
Number of subjects: 12
Study: 28801967

Group type: EXPERIMENTAL
Intervention: Experimental retreatment with subcutaneous bortezomib plus dexamethasone (VD)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard VD retreatment
Number of subjects: 80
Study: 26748537

Group type: EXPERIMENTAL
Intervention: Pessary placement
Number of subjects: 808

Group type: COMPARATOR
Intervention: Control (no pessary)
Number of subjects: 808
Study: 24345356

Group type: EXPERIMENTAL
Intervention: Treatment as usual with smoking-cessation treatment (weekly individual smoking cessation counseling and extended-release bupropion 300 mg/d during weeks 1-10, nicotine inhaler and contingency management for smoking abstinence during weeks 4-10)
Number of subjects: 538

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Treatment as usual with smoking-cessation treatment
Number of subjects: 538
Study: 23027228

Group type: EXPERIMENTAL
Intervention: Mindfulness induction
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 19954496

Group type: EXPERIMENTAL
Intervention: Football group (FG)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Running group (RG)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (CO)
Number of subjects: 53
Study: 19894661

Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass surgery
Number of subjects: 1966
Study: 16802260

Group type: EXPERIMENTAL
Intervention: Manualized procedure with five brief contacts
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 0
Study: 12492746

Group type: EXPERIMENTAL
Intervention: Forlax (10 g)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Forlax (20 g)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transipeg (5.9 g)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transipeg (11.8 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 10844354

Group type: EXPERIMENTAL
Intervention: Cemented total knee arthroplasty
Number of subjects: 96

Group type: COMPARATOR
Intervention: Uncemented total knee arthroplasty
Number of subjects: 96

Group type: COMPARATOR
Intervention: Noncemented total knee arthroplasty
Number of subjects: 96
Study: 9337835

Group type: EXPERIMENTAL
Intervention: Inhalation of gas mixtures with varying fractional inspired oxygen concentration (FiO2) from 0.1 to 1.0
Number of subjects: 16

Group type: COMPARATOR
Intervention: Inhalation of gas mixtures with FiO2 of 0.1
Number of subjects: 16
Study: 8449125

Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins (vitamin A 30,000 IU/day, vitamin C 1 g/day, vitamin E 70 mg/day)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Lactulose (20 g/day)
Number of subjects: 209

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 209
Study: 2869676

Group type: EXPERIMENTAL
Intervention: Verapamil (80 to 160 mg 3 times a day)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Propranolol (40 to 120 mg 3 times a day)
Number of subjects: 17
Study: 29864732

Group type: EXPERIMENTAL
Intervention: Telephone-delivered mindfulness-based cognitive therapy (MBCT-T)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 144
Study: 27825738

Group type: COMPARATOR
Intervention: Dihydroartemisinin-piperaquine (DHAP) alone
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHAP) + Primaquine 0.20mg/kg
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHAP) + Primaquine 0.40mg/kg
Number of subjects: 694

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHAP) + Primaquine 0.75mg/kg
Number of subjects: 694
Study: 25525171

Group type: EXPERIMENTAL
Intervention: Intravitreal sirolimus
Number of subjects: 6

Group type: COMPARATOR
Intervention: Fellow eye (control)
Number of subjects: 6
Study: 22483737

Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guidelines for delineation of the postoperative CTV and normal tissues
Number of subjects: 0
Study: 20531202

Group type: EXPERIMENTAL
Intervention: Olopatadine 0.1%
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Fluorometholone 0.1%
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both olopatadine and fluorometholone
Number of subjects: 85
Study: 18803955

Group type: EXPERIMENTAL
Intervention: Telmisartan 47.0 mg/d
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Candesartan 8.4 mg/d
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (no change in drug regimen)
Number of subjects: 153
Study: 16169302

Group type: EXPERIMENTAL
Intervention: 6 mg nicotine enema
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Nicotine therapy
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Sigmoidoscopy
Number of subjects: 48
Study: 11974560

Group type: EXPERIMENTAL
Intervention: CEE/MPA 0.625 mg-5.0 mg daily for 13 treatment cycles (28 days each)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Tibolone 2.5 mg daily for 13 treatment cycles (28 days each)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both CEE/MPA and Tibolone
Number of subjects: 85